Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy
Journal article published in 2017 by
Nicolas Fissolo,
Juan Carlos Triviño,
Béatrice Pignolet,
Clara Matute-Blanch,
Patrick Vermersch,
Berta Miró 
,
Jérôme de Sèze,
Miriam Mota,
Sandra Vukusic,
Santiago Perez-Hoyos,
Alex Sanchez ,
Ayman Tourbah,
Aurélie Ruet,
Pierre Labauge,
Caroline Papeix
and other authors.
,
Jérôme de Sèze,
Miriam Mota,
Sandra Vukusic,
Santiago Perez-Hoyos,
Alex Sanchez ,
Ayman Tourbah,
Aurélie Ruet,
Pierre Labauge,
Caroline Papeix
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 